The American Society of Clinical Oncology (ASCO) is working to define value in cancer care to help individual physicians and their patients make the wisest choices among their potential cancer treatment options. This effort is part of ASCO’s long-standing mission to improve access to high-quality, high-value care for every patient with cancer. Defining value: The best care for each patient ASCO’s Value in Cancer Care Task Force defines value as the combination of three factors for a cancer treatment regimen: clinical benefit, toxicity (side effects), and cost. These are the factors that matter most to our patients. From the patient’s standpoint, it means getting the best possible outcomes consistent with his or her own personal preferences ...
BackgroundDetermination of the comparative efficacy of one therapy over another for hepatocellular c...
The debate around value in oncology drug selection has been prominent in recent years, and several ...
In the current health care system, high costs without proportional improvements in quality or outcom...
As members of the International Society for Pharmacoeconomics and Outcomes Research, we read with gr...
There is a consensus about the danger that spiraling health care costs presents to the well-being of...
Recently, professional and healthcare-related entities have launched frameworks designed to assess t...
The last few years have seen the development of several “value frameworks” for assessing the relativ...
Confronted with the different clinical impacts of different treatments, the rising cost of cancer ca...
In the current climate of escalating health care costs, defining value and accurately measuring it a...
Since 2012, ASCO has sponsored its annual Quality Care Symposium. In developing this symposium, ASCO...
In the current health care system, high costs without proportional improvements in quality or outcom...
Globally, an increasing and aging population is contributing to the prevalence of cancer. To be effe...
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization re...
cology (ASCO) has witnessed dramatic advances in our un-derstanding and management of cancer. Condit...
Rising cancer drug costs within the United States have raised questions regarding the accessibility ...
BackgroundDetermination of the comparative efficacy of one therapy over another for hepatocellular c...
The debate around value in oncology drug selection has been prominent in recent years, and several ...
In the current health care system, high costs without proportional improvements in quality or outcom...
As members of the International Society for Pharmacoeconomics and Outcomes Research, we read with gr...
There is a consensus about the danger that spiraling health care costs presents to the well-being of...
Recently, professional and healthcare-related entities have launched frameworks designed to assess t...
The last few years have seen the development of several “value frameworks” for assessing the relativ...
Confronted with the different clinical impacts of different treatments, the rising cost of cancer ca...
In the current climate of escalating health care costs, defining value and accurately measuring it a...
Since 2012, ASCO has sponsored its annual Quality Care Symposium. In developing this symposium, ASCO...
In the current health care system, high costs without proportional improvements in quality or outcom...
Globally, an increasing and aging population is contributing to the prevalence of cancer. To be effe...
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization re...
cology (ASCO) has witnessed dramatic advances in our un-derstanding and management of cancer. Condit...
Rising cancer drug costs within the United States have raised questions regarding the accessibility ...
BackgroundDetermination of the comparative efficacy of one therapy over another for hepatocellular c...
The debate around value in oncology drug selection has been prominent in recent years, and several ...
In the current health care system, high costs without proportional improvements in quality or outcom...